Navigation Links
Radiation Oncology Services of America, Inc. Announces Formation of Scientific Advisory Board
Date:9/18/2008

NASHVILLE, Tenn., Sept. 18 /PRNewswire/ -- Radiation Oncology Services of America, Inc. (ROSA), a subsidiary of Ambulatory Services of America, Inc., announced today the inaugural meeting of its Scientific Advisory Board in Dallas, Texas on September 12, 2008. The Scientific Advisory Board is comprised of a diverse group of leaders in the radiation oncology field. It will advise ROSA on numerous scientific and clinical issues including research initiatives, practice patterns and emerging technologies. Board members include: Lawrence R. Coia, M.D., of East Coast Radiation Oncology Associates in Toms River, New Jersey; Dennis E. Hallahan, M.D., Chair of Radiation Oncology at Vanderbilt University in Nashville, Tennessee; Richard T. Hoppe, M.D., Chair of Radiation Oncology at Stanford University in Stanford, California; George E. Laramore, Ph.D., M.D., Chair of Radiation Oncology at the University of Washington in Seattle, Washington; Erich Randolph, M.D., of Atlanta Oncology Associates in Atlanta, Georgia; and J. Warner Ray, M.D., of Radiation Oncology Services in Atlanta, Georgia.

The inaugural meeting was led by Vincent W. Dennis, M.D., Senior Medical Advisor for Ambulatory Services of America, who said, "The Scientific Advisory Board will be a key instrument in positioning ROSA to improve its services to our radiation oncology partners and their patients now and in the future." Greg Merrill, Chief Operating Officer of ROSA, also participated and said, "The formation of the Scientific Advisory Board is another important step in ROSA's commitment to build a healthcare company of the highest quality using a physician-driven approach complemented by an experienced management team."

Tim Martin, President and Chief Executive Officer of ROSA's parent company, Ambulatory Services of America, said, "Physician leadership is essential to making sure that the best technology is available for the right patients at the right time. Bringing physician leaders together to be part of that important work is a key ROSA objective."

Radiation Oncology Services of America, Inc., headquartered in Brentwood, Tennessee owns interests in, operates and manages 13 radiation therapy facilities in five states. Ambulatory Services of America, Inc., headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians. ASA, through its primary subsidiaries Radiation Oncology Services of America, Inc. and Innovative Dialysis Systems, Inc., owns interests in, operates and manages a total of more than 50 facilities providing radiation oncology services and dialysis services in ten states and the territory of Guam.


'/>"/>
SOURCE Radiation Oncology Services of America, Inc. (ROSA)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Radiation Oncology Institute Campaign Raises $3 Million
2. Dr. Chad Levitt Joins North Georgia Radiation Oncology Center
3. Drug/radiation combo may help shrink established tumors
4. Grocery Manufacturers Association Strongly Supports U.S. Food & Drug Administration Decision on the Irradiation of Fresh Produce for Foodborne Pathogen Control
5. Targeted radiation therapy can control limited cancer spread
6. Sweden to Receive Scandinavia's First TomoTherapy System : Lund University Hospital to Offer Swedish Cancer Patients the Most Advanced Image-Guided Radiation Therapy Treatments
7. BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy
8. Treating rare breast cancer with radiation therapy may lower recurrence rate
9. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Chicago-Area Radiation Oncology Facility
10. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Radiation Oncology Facility in Dallas, Texas
11. Radiation for health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... Japanese Zen ... Yoga Mat Revolution” on 6th, 7th and 8th October at Miranda Kuo Gallery on ... mat art pieces, such as Zen Kodo mat. Wanderlust , one of the ...
(Date:9/21/2017)... Boulder, CO (PRWEB) , ... September 21, 2017 ... ... Education Interview of the Month, Lewis and Clark College Emeritus Professor of Education ... Associate Faith Boninger, co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... voice for people who have kidney disease. The theme “Describe a positive decision ... stories. Entrants needed to meet only one qualification— to have been diagnosed ...
(Date:9/20/2017)... ... September 20, 2017 , ... Announced ... Aligner clinical and commercial support services market) has entered into an agreement on ... Australia. , The PGSD is the first private Dental School to launch ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Honey Pot ... Vaginas.” The goal is to ignite conversation via social media and word-of-mouth regarding ... brand has declared September “Humans with Vaginas” month, releasing a video celebrating the ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology: